openPR Logo
Press release

Lucintel Forecasts the Global Prenatal Testing & Newborn Screening Market $17.9 billion by 2031

09-18-2025 01:41 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Lucintel

Prenatal Testing & Newborn Screening Market

Prenatal Testing & Newborn Screening Market

According to a market report by Lucintel, the future of the global prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets. The global prenatal testing & newborn screening market is expected to reach an estimated $17.9 billion by 2031 with a CAGR of 11.3% from 2025 to 2031. The major drivers for this market are the growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.
A more than 150-page report to understand trends, opportunity and forecast in prenatal testing & newborn screening market to 2031 by diagnostic type (invasive and non-invasive), technology (screening technology and diagnostic technology), end use (hospitals, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)..
Lucintel forecasts that, within the diagnostic type category, non-invasive is expected to witness a higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.
Within the end use category, hospital is expected to witness a higher growth over the forecast perioddue to growing patients preference for this facility to make informed decisions.
Download sample by clicking on prenatal testing & newborn screening market
In terms of region, North America is expected to witness the highest growth over the forecast period due to growing number of genetic disorders cases and presence of favorable reimbursement policy in the region.
Perkinelmer, Natera, Invitae, Centogene, Cradle Genomics, Hoffmann-La Roche, Quest Diagnostics, Baebies, Ravgen, Eurofins Scientific are the major suppliers in the prenatal testing & newborn screening market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Colorant for Synthetic Leather Market
Modified Novolac Epoxy Resin Market
VLP Ultra Low Profile Copper Foil Market
RTF Reverse Copper Foil Market
Thermal Recording Paper Market

8951 Cypress Waters Blvd, Suite 160 Dallas, TX 75019, USA
Tel: +1-972-636-5056

Lucintel is the one of the world's most reputed market research report company which provides market intelligence services that free up your market research and strategic planning resources (time, money and people) and allows you to focus on your core business. We assist you in the utilization of the best market intelligence for greater business gains and we do it faster, better and cheaper. Lucintel offers unmatched data and report quality as compared to the other market research report companies with highest customer satisfaction. Browse market research reports by the below sectors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lucintel Forecasts the Global Prenatal Testing & Newborn Screening Market $17.9 billion by 2031 here

News-ID: 4187365 • Views:

More Releases from Lucintel

Lucintel Forecasts the Global Uterine Cancer Diagnostics Market to reach $11.2 billion by 2030
Lucintel Forecasts the Global Uterine Cancer Diagnostics Market to reach $11.2 b …
According to a market report by Lucintel, the future of the global uterine cancer diagnostics market looks promising with opportunities in the hospital, diagnostic center, and cancer research center markets. The global uterine cancer diagnostics market is expected to reach an estimated $11.2 billion by 2030 with a CAGR of 9.0% from 2024 to 2030. The major drivers for this market are the increasing cases of uterine cancer, technological advancement
Lucintel Forecasts the Global Thyroid Cancer Diagnostic Market to Reach $7.6 billion by 2030
Lucintel Forecasts the Global Thyroid Cancer Diagnostic Market to Reach $7.6 bil …
According to a market report by Lucintel, the future of the global thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets. The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030 from $5.5 billion in 2024, at a CAGR of 5.5% from 2024 to 2030. The major drivers for
Lucintel Forecasts the Global Skin Cancer Diagnostics & Therapeutics Market to Reach $18.1 billion by 2030
Lucintel Forecasts the Global Skin Cancer Diagnostics & Therapeutics Market to R …
According to a market report by Lucintel, the future of the global skin cancer diagnostics & therapeutics market looks promising with opportunities in the diagnosis and therapeutic markets. The global skin cancer diagnostics & therapeutics market is expected to reach an estimated $18.1 billion by 2030 from $13.5 billion in 2024, at a CAGR of 5.0% from 2024 to 2030. The major drivers for this market are increasing government initiatives
ucintel Forecasts the Global Ovarian Cancer Diagnostics Market to Reach $2.3 billion by 2030
ucintel Forecasts the Global Ovarian Cancer Diagnostics Market to Reach $2.3 bil …
According to a market report by Lucintel, the future of the global ovarian cancer diagnostics market looks promising with opportunities in the cancer diagnostic center, hospital laboratory, and research institute markets. The global ovarian cancer diagnostics market is expected to reach an estimated $2.3 billion by 2030 from $1.5 billion in 2024, at a CAGR of 6.9% from 2024 to 2030. The major drivers for this market are growing prevalence

All 5 Releases


More Releases for Prenatal

Non-Invasive Prenatal Testing (NIPT) Market Set to Transform Prenatal Care World …
Market Overview The global non-invasive prenatal testing NIPT market reached US$ 6.31 billion in 2023 and increased to US$ 7.35 billion in 2024. It is projected to reach US$ 22.41 billion by 2033, growing at a compound annual growth rate CAGR of 13.2% during the forecast period 2025-2033. The market is driven by the rising prevalence of chromosomal abnormalities, increasing maternal age, and growing demand for safe, non-invasive screening methods. NIPT
Unlocking the Future of Prenatal Care: Insights into the Australia Non-Invasive …
Australia's NIPT market is growing as more parents choose safe, early screening for chromosomal abnormalities. Driven by rising maternal age, advanced sequencing technology, and increasing awareness, NIPT offers high accuracy without invasive procedures. As labs expand test panels and policymakers consider broader reimbursement, NIPT is reshaping prenatal care, making comprehensive and reliable insights accessible to expecting families across Australia. The Australian non-invasive prenatal testing (NIPT) market is undergoing remarkable growth, transforming
Revolutionizing Prenatal Care: Insights into the Growing Non-Invasive Prenatal T …
Mordor Intelligence has published a new report on the Non-invasive Prenatal Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global non-invasive prenatal testing (NIPT) market is projected to expand significantly, with expectations to grow from USD 3.90 billion in 2025 to USD 7.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.5%. This growth is primarily attributed to
Prenatal Diagnostics Market Companies Overview 2019 - 2027
Global Prenatal Diagnostics Market: Overview Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down's syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening. Report Overview @ https://www.transparencymarketresearch.com/prenatal-diagnostics-market.html The global prenatal diagnostics market is segmented on
Non-Invasive Prenatal Testing Market : Lucrative Opportunities
Non-Invasive Prenatal Testing Market: Introduction Transparency Market Research has published a new report titled 'Global Non-Invasive Prenatal Testing Market'. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027. Overview Rise in prevalence of chronic conditions, such as cancer and diabetes,
Prenatal Vitamin Supplements Market: Rising Incidence of Prenatal Defects to Fue …
Global Prenatal Vitamin Supplements Market: Overview Prenatal vitamins are the mineral and vitamin supplements used by during their pregnancy for the healthy development of the fetus. Prenatal vitamins are also recommended by doctors before conception and post conception lactation period. These vitamins are like other common man multivitamins but with different concentration of vitamins and some special vitamins required during pregnancy. Most of these vitamins are prescribed as regulated by U.S.